Cleerly, a company in the field of heart disease care, has been named the winner of the coveted “Best Overall AI Solution” award in the sixth annual AI Breakthrough Awards program. This recognition highlights Cleerly’s commitment to transforming the landscape of cardiovascular care through innovative AI-powered solutions.
Cleerly’s digital care platform empowers physicians to precisely identify, define, and treat heart disease in its earliest stages, when intervention is most effective. At the core of the platform is non-invasive coronary computed tomography angiography (CCTA), which leverages AI-powered and FDA-cleared solutions. By analyzing millions of annotated lab images and employing proprietary algorithms, Cleerly’s technology allows for comprehensive coronary artery phenotyping. It quantifies and characterizes the presence, extent, severity, and type of coronary artery disease (CAD) and other cardiovascular disorders.
Through advanced machine learning and AI capabilities, Cleerly enables healthcare providers to perform comprehensive assessments of a patient’s CCTA. This assessment, completed in just seven minutes, provides a patient’s risk profile for CAD. Cleerly’s diagnostic tools and personalized reporting solutions cater to all stakeholders in the heart care pathway, including patients. The precision and depth of the analysis aid healthcare providers in delivering targeted and effective treatment plans.
Dr. James K. Min, founder and CEO of Cleerly, envisions a world without heart attacks and believes in the transformative power of AI in identifying health issues swiftly and accurately. Cleerly’s solution, coupled with ongoing refinements, aims to identify individuals at risk of heart disease and prevent heart attacks before they occur. By emulating successful preventive care paradigms in early cancer detection, Cleerly strives to redefine cardiovascular care and improve patient outcomes.
The AI Breakthrough Awards program acknowledges excellence in various AI and machine learning categories, celebrating innovation, hard work, and success in the global AI market. Cleerly’s breakthrough use of AI for whole-heart quantification and characterization of actual heart disease distinguishes it as the “Best Overall AI Solution.” By pioneering advanced imaging techniques and precision prevention approaches, Cleerly is at the forefront of transforming cardiovascular care.
